Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Which yoga poses complement lipitor's heart healthy effects?Is fatigue a typical lipitor side effect?Are there specific liver function tests recommended with tigecycline?Can generic versions of kadcyla save costs?Is it safe to take vascepa with dietary supplements?
See the DrugPatentWatch profile for imbruvica
What is the real-world success rate of Imbruvica for mantle cell lymphoma? Real-world studies report overall response rates of 66% and progression-free survival around 15 months, compared with clinical trial results of 66-68% overall response rates and 14-21 months progression-free survival. Real-world data often show etwas tiefer response rates than trials, but still significant clinical benefit. Why do clinical trials and real-world data differ? Trial patients are usually younger, fit enough to meet inclusion criteria, and have fewer comorbidities than patients treated in routine practice. Com comorbidities often affect a patient's ability to stop or adjust dose due to side effects.
Other Questions About Imbruvica :